To further assess localization of TIMP-1 in human prostate cancers and determine the potential source(s) of the elevated plasma TIMP-1, we performed immunohistochemistry (IHC) on a panel of human prostate cancer samples and normal prostate tissues. The gene discussed is TIMP1; the disease is prostate cancer.